By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Phenothiazine antiemetics > Chlorpromazine > Chlorpromazine Side Effects
Phenothiazine antiemetics

Chlorpromazine Side Effects

Applies to chlorpromazine: oral tablets, parenteral injection.

Warning

    Increased Mortality in Geriatric Patients with Dementia-related Psychosis
  • Geriatric patients with dementia-related psychosis treated with antipsychotic agents are at an increased risk of death.101 105 106 n

  • Analyses of 17 placebo-controlled trials in geriatric patients mainly receiving atypical antipsychotic agents revealed an approximate 1.6- to 1.7-fold increase in mortality compared with that in patients receiving placebo.101 105 106 n

  • Most fatalities appeared to result from cardiovascular-related events (e.g., heart failure, sudden death) or infections (mostly pneumonia).105 106 n

  • Observational studies suggest that conventional or first-generation antipsychotic agents also may increase mortality in such patients.101 105 106

  • Antipsychotic agents, including chlorpromazine, are not approved for the treatment of dementia-related psychosis.101 105 106 n

Side effects include:

Extrapyramidal reactions (e.g., Parkinson-like symptoms, dystonia, akathisia, tardive dyskinesia), drowsiness, dizziness, skin reactions or rash, dry mouth, orthostatic hypotension, amenorrhea, galactorrhea, weight gain.

For Healthcare Professionals

Applies to chlorpromazine: compounding powder, injectable solution, oral capsule extended release, oral concentrate, oral syrup, oral tablet, rectal suppository.

General

The most frequently reported side effects included drowsiness, sedation, dry mouth, and nasal stuffiness.[Ref]

Hematologic

Very common (10% or more): Mild leukopenia (up to 30%)

Common (1% to 10%): Agranulocytosis, leukopenia, eosinophilia, hemolytic anemia, aplastic anemia, thrombocytopenia purpura, pancytopenia

Uncommon (0.1% to 1%): Purpura, leukocytosis, coagulation defects[Ref]

Nervous system

Acute dystonia and/or dyskinesia typically were transitory, occurring more frequently in children and young adults within the first 4 days of treatment or after dose changes.

Akathisia usually occurred after patients were given large initial doses.

Autonomic dysfunction occurred as a symptom of neuroleptic malignant syndrome.

Convulsive seizures have occurred more frequently in patients with a history of seizures and/or with EEG abnormalities.

Momentary fainting occurred most commonly in patients after the first injection, with a lower frequency of occurrence in subsequent injections; patients given oral formulations rarely fainted after the initial dose.

Parkinsonism more commonly occurred in adults and elderly patients after weeks to months of treatment.

Sedation and somnolence occurred more frequently at the start of treatment.[Ref]

Common (1% to 10%): Hypertonia, tardive dyskinesia, tardive dystonia, extrapyramidal syndrome, akathisia, parkinsonism, motor restlessness, drowsiness, convulsion/convulsive seizures (petit mal and grand mal), lowering of the seizure threshold, acute dyskinesia or dystonia

Uncommon (0.1% to 1%): Cerebral edema, epileptic fits, neuroleptic malignant syndrome, myasthenia gravis, abnormality of cerebrospinal fluid proteins

Frequency not reported: Lethargy, akinesia, hyperkinesia, autonomic dysfunction, tremor, drooling, pill rolling motion, cogwheel rigidity, shuffling gait, rhythmical involuntary movements of the tongue/face/mouth/jaw, involuntary movements of the extremities, fine vermicular movements of the tongue, dizziness, headache, momentary fainting, pseudo-parkinsonism, mask-like facies

Postmarketing reports: Cerebrovascular adverse events[Ref]

Gastrointestinal

Common (1% to 10%): Dry mouth, constipation, nausea, obstipation, adynamic ileus, atonic colon

Uncommon (0.1% to 1%): Paralytic ileus

Postmarketing reports: Ischemic colitis, intestinal perforation/fatal intestinal perforation, gastrointestinal (GI) necrosis/fatal GI necrosis, intestinal obstruction, tongue protrusion, difficulty swallowing, necrotizing colitis/fatal necrotizing colitis[Ref]

Psychiatric

Altered consciousness occurred as a symptom of neuroleptic malignant syndrome.[Ref]

Common (1% to 10%): Anxiety, mental confusion, agitation, excitement, aggravation of schizophrenic symptoms

Uncommon (0.1% to 1%): Nightmares, dysphoria, catatonic excitement, mental dulling/slowing

Rare (0.01% to 0.1%): Psychotic symptoms, catatonic-like states

Frequency not reported: Insomnia, altered mood, altered consciousness[Ref]

Ocular

Accommodation disorder was related to anticholinergic effects of this drug.

Eye deposits occurred in the anterior segment of the eye from drug accumulation; however, the deposits usually did not have impact on sight.[Ref]

Common (1% to 10%): Blurred vision, photophobia, corneal/eye deposits, miosis and mydriasis

Uncommon (0.1% to 1%): Optic atrophy, lens opacities, pigmentary retinopathy, precipitation/aggravation of narrow angle glaucoma

Frequency not reported: Oculogyric crisis, ocular changes, accommodation disorder[Ref]

Genitourinary

Common (1% to 10%): Urinary retention/hesitancy, priapism, ejaculation disorders/impotence

Uncommon (0.1% to 1%): Amenorrhea, incontinence, lactation and moderate breast engorgement (female patients)

Frequency not reported: Galactorrhea, oligomenorrhea, erectile dysfunction, female sexual arousal disorder[Ref]

Lactation and breast engorgement in female patients occurred with large doses.

Urinary retention was linked to anticholinergic effects of this drug.[Ref]

Dermatologic

Common (1% to 10%): Contact dermatitis, photosensitivity/photosensitivity reaction, urticarial/maculopapular/petechial or edematous reaction

Uncommon (0.1% to 1%): Skin pigmentation, exfoliative dermatitis, toxic epidermal necrolysis

Frequency not reported: Allergic dermatitis, skin rashes

Postmarketing reports: Angioneurotic edema[Ref]

Metabolic

Common (1% to 10%): Impaired glucose tolerance, hyperglycemia, weight gain

Uncommon (0.1% to 1%): Hypoglycemia, water retention

Postmarketing reports: Hypertriglyceridemia, hyponatremia, increased appetite[Ref]

Cardiovascular

Common (1% to 10%): Orthostatic/postural hypotension, ECG changes (electrocardiogram QT prolongation, ST depression, U-Wave and T-Wave changes)

Uncommon (0.1% to 1%): Arrhythmias, hypertensive crisis, AV block, ventricular tachycardia/tachycardia, QT prolongation and fibrillation, edema, labile blood pressure

Frequency not reported: Ventricular fibrillation, Torsade de pointes, cardiac arrest, sudden cardiac death, profound hypotension, peripheral edema, venous embolism, deep vein thrombosis, cardiac arrhythmias (including ventricular and atrial arrhythmias)[Ref]

Cardiac arrest may be related to dose as well as preexisting conditions (e.g., cardiac disease, old age, hypokalemia, concurrent tricyclic antidepressants).

Hypertensive crisis occurred after abrupt withdrawal of treatment.

Orthostatic hypotension occurred more frequently in elderly and/or volume depleted patients, and was more likely to occur with IM administration.

Sudden cardiac death may be related to causes of cardiac origin.[Ref]

Endocrine

Common (1% to 10%): Hypothalamic effects, hyperprolactinemia/elevated prolactin levels

Uncommon (0.1% to 1%): Gynecomastia, profuse sweating, false positive pregnancy tests, inappropriate antidiuretic hormone secretion[Ref]

Other

Hyperthermia occurred as a symptom of neuroleptic malignant syndrome.

Mild fevers have occurred in patient who received large doses intramuscularly.

Sudden death may be related to causes of cardiac origin, asphyxia, convulsions, or hyperpyrexia.[Ref]

Common (1% to 10%): Paradoxical reactions, impaired thermoregulation/temperature regulation disorder

Uncommon (0.1% to 1%): Hyperthermia, hypothermia, malignant hyperpyrexia

Frequency not reported: Sudden death, jitteriness, neonatal drug withdrawal syndrome[Ref]

Respiratory

Common (1% to 10%): Nasal congestion/stuffiness, respiratory depression

Uncommon (0.1% to 1%): Dyspnea

Frequency not reported: Bronchospasm, pulmonary embolism/fatal pulmonary embolism

Postmarketing reports: Asthma, laryngeal edema, throat tightness, asphyxia (failure of the cough reflex)[Ref]

Local

Contact sensitization has occurred in individuals who frequently handled this drug.[Ref]

Common (1% to 10%): Injection site pain, injection abscess

Uncommon (0.1% to 1%): Contact skin sensitization[Ref]

Immunologic

Common (1% to 10%): Positive systemic lupus erythematosus (SLE) cells, antinuclear antibody (ANA) positive/raised ANA titer[Ref]

Hepatic

Common (1% to 10%): Cholestatic jaundice

Uncommon (0.1% to 1%): Liver injury, fatal liver injury, cholestatic/hepatocellular or mixed liver injury

Frequency not reported: Progressive hepatic fibrosis[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Elevated creatine phosphokinase, muscular rigidity/rigidity, myoglobinuria/rhabdomyolysis

Rare (0.01% to 0.1%): Systemic lupus erythematosus

Frequency not reported: Torticollis, trismus

Postmarketing reports: Prolonged, abnormal muscle contractions, neck muscle spasms[Ref]

Elevated creatine phosphokinase, muscular rigidity, and myoglobinuria/rhabdomyolysis are symptoms of neuroleptic malignant syndrome.

Rigidity occurred as a symptom of neuroleptic malignant syndrome.[Ref]

Renal

Uncommon (0.1% to 1%): Glycosuria, acute renal failure[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Severe allergic reactions/allergic reactions

Rare (0.01% to 0.1%): Anaphylactic/anaphylactoid reactions

Frequency not reported: Angioedema[Ref]

Share this Article
Latest News
Medical News

Obesity, unhealthy lifestyles may cause heart to age by 5–45 years

May 08, 2025
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Heart disease: Just 3 minutes of 'incidental activity' may lower...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by